{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:51:10Z","timestamp":1791967870731,"version":"4.3.4"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ebiom.2026.106467","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:49:42Z","timestamp":1788288582000},"page":"106467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Integration of biological avatars and digital twins for \u201cex vivo clinical trials\u201d"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3889-8739","authenticated-orcid":false,"given":"Charles L.","family":"Howe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ebiom.2026.106467_bib1","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s41416-020-01033-x","article-title":"Pre-clinical animal models are poor predictors of human toxicities in phase 1 oncology clinical trials","volume":"123","author":"Atkins","year":"2020","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106467_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/d41573-019-00074-z","article-title":"Trends in clinical success rates and therapeutic focus","volume":"18","author":"Dowden","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106467_bib3","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/d41573-024-00131-2","article-title":"Comprehensive measurement of biopharmaceutical R&D investment","volume":"23","author":"Chandra","year":"2024","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106467_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.15445","article-title":"Costs of drug development and research and development intensity in the US, 2000-2018","volume":"7","author":"Sertkaya","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106467_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nbt.2786","article-title":"Clinical development success rates for investigational drugs","volume":"32","author":"Hay","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106467_bib6","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nrd.2016.184","article-title":"Phase II and phase III failures: 2013-2015","volume":"15","author":"Harrison","year":"2016","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106467_bib7","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa063842","article-title":"Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412","volume":"355","author":"Suntharalingam","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106467_bib8","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/bcp.12920","article-title":"Implications of the BIA-102474-101 study for review of first-into-human clinical trials","volume":"81","author":"Eddleston","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106467_bib9","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41551-024-01236-0","article-title":"Standardizing designed and emergent quantitative features in microphysiological systems","volume":"8","author":"Nahon","year":"2024","journal-title":"Nat Biomed Eng"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106467_bib10","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling development and disease with organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106467_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1152\/physrev.00039.2017","article-title":"Induced pluripotent stem cells and their use in human models of disease and development","volume":"99","author":"Karagiannis","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ebiom.2026.106467_bib12","article-title":"Organoid factory: the recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine","volume":"10","author":"Novelli","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106467_bib14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.amjmed.2023.03.033","article-title":"The FDA Modernization Act 2.0: drug testing in animals is rendered optional","volume":"136","author":"Adashi","year":"2023","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106467_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-pharmtox-022724-095035","article-title":"Next-Gen therapeutics: pioneering drug discovery with iPSCs, genomics, AI, and clinical trials in a dish","volume":"65","author":"Yildirim","year":"2025","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106467_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41746-024-01402-3","article-title":"Challenges and opportunities for digital twins in precision medicine from a complex systems perspective","volume":"8","author":"De Domenico","year":"2025","journal-title":"NPJ Digit Med"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106467_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCULATIONAHA.123.065585","article-title":"FDA Modernization Act 2.0 paves the way to computational biology and clinical trials in a dish","volume":"148","author":"Ahmed","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ebiom.2026.106467_bib18","series-title":"Standard terminology relating to microphysiological systems","year":"2022"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106467_bib19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.stem.2008.09.002","article-title":"Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals","volume":"3","author":"Eiraku","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"7244","key":"10.1016\/j.ebiom.2026.106467_bib20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"issue":"7332","key":"10.1016\/j.ebiom.2026.106467_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature09691","article-title":"Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro","volume":"470","author":"Spence","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106467_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nmeth.4575","article-title":"Method of the year 2017: organoids","volume":"15","year":"2018","journal-title":"Nat Methods"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106467_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41591-024-03489-3","article-title":"Clinical applications of human organoids","volume":"31","author":"Verstegen","year":"2025","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106467_bib24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41576-022-00466-9","article-title":"Human organs-on-chips for disease modelling, drug development and personalized medicine","volume":"23","author":"Ingber","year":"2022","journal-title":"Nat Rev Genet"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106467_bib25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective derivation of a living organoid biobank of colorectal cancer patients","volume":"161","author":"van de Wetering","year":"2015","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106467_bib26","doi-asserted-by":"crossref","first-page":"G693","DOI":"10.1152\/ajpgi.00043.2021","article-title":"Intestinal organoids in coculture: redefining the boundaries of gut mucosa ex vivo modeling","volume":"321","author":"Hentschel","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106467_bib27","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1113\/jphysiol.2014.283028","article-title":"The use of murine-derived fundic organoids in studies of gastric physiology","volume":"593","author":"Schumacher","year":"2015","journal-title":"J Physiol"},{"key":"10.1016\/j.ebiom.2026.106467_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3710836","article-title":"Three-dimensional gastrointestinal organoid culture in combination with nerves or fibroblasts: a method to characterize the gastrointestinal stem cell niche","volume":"2016","author":"Pastula","year":"2016","journal-title":"Stem Cells Int"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106467_bib29","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"issue":"7909","key":"10.1016\/j.ebiom.2026.106467_bib30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41586-022-04593-5","article-title":"Chemical reprogramming of human somatic cells to pluripotent stem cells","volume":"605","author":"Guan","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2026.106467_bib31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ceb.2019.07.009","article-title":"Recent advances in deriving human endodermal tissues from pluripotent stem cells","volume":"61","author":"Kechele","year":"2019","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.ebiom.2026.106467_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1169331","article-title":"Extracellular matrix cues regulate the differentiation of pluripotent stem cell-derived endothelial cells","volume":"10","author":"Noh","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106467_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5966\/sctm.2013-0110","article-title":"Small molecule-mediated directed differentiation of human embryonic stem cells toward ventricular cardiomyocytes","volume":"3","author":"Karakikes","year":"2014","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.ebiom.2026.106467_bib34","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.reth.2024.12.014","article-title":"Interplay between pioneer transcription factors and epigenetic modifiers in cell reprogramming","volume":"28","author":"Mirizio","year":"2025","journal-title":"Regen Ther"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106467_bib35","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1073\/pnas.0910012107","article-title":"Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency","volume":"107","author":"Hu","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7467","key":"10.1016\/j.ebiom.2026.106467_bib36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"issue":"7929","key":"10.1016\/j.ebiom.2026.106467_bib37","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41586-022-05219-6","article-title":"A nomenclature consensus for nervous system organoids and assembloids","volume":"609","author":"Pasca","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106467_bib38","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.stemcr.2017.05.017","article-title":"A highly efficient human pluripotent stem cell microglia model displays a neuronal-co-culture-specific expression profile and inflammatory response","volume":"8","author":"Haenseler","year":"2017","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.ebiom.2026.106467_bib39","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.76707","article-title":"Generation of vascularized brain organoids to study neurovascular interactions","volume":"11","author":"Sun","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.ebiom.2026.106467_bib40","article-title":"Development and implementation of large-scale quality control for the European bank for induced pluripotent stem cells","volume":"45","author":"O\u2019Shea","year":"2020","journal-title":"Stem Cell Res"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106467_bib41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12015-015-9622-8","article-title":"Choices for induction of pluripotency: recent developments in human induced pluripotent stem cell reprogramming strategies","volume":"12","author":"Brouwer","year":"2016","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.ebiom.2026.106467_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1049965","article-title":"Recent advances in engineering hydrogels for niche biomimicking and hematopoietic stem cell culturing","volume":"10","author":"Huang","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.ebiom.2026.106467_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2023.115355","article-title":"Advances in TEER measurements of biological barriers in microphysiological systems","volume":"234","author":"Nazari","year":"2023","journal-title":"Biosens Bioelectron"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106467_bib44","first-page":"204","article-title":"Biology-inspired dynamic microphysiological system approaches to revolutionize basic research, healthcare and animal welfare","volume":"42","author":"Marx","year":"2025","journal-title":"ALTEX"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106467_bib45","first-page":"137","article-title":"Advances in human induced pluripotent stem cell (hiPSC)-based disease modelling in cardiogenetics","volume":"37","author":"Hoffmann","year":"2025","journal-title":"Med Genet"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106467_bib46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41522-024-00501-z","article-title":"An immune-competent human gut microphysiological system enables inflammation-modulation by Faecalibacterium prausnitzii","volume":"10","author":"Zhang","year":"2024","journal-title":"NPJ Biofilms Microb"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106467_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/stcltm\/szaf031","article-title":"The need for an organoid manufacturing, preservation, and distribution center","volume":"14","author":"Atala","year":"2025","journal-title":"Stem Cells Transl Med"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106467_bib49","article-title":"Considerations from an international regulatory and pharmaceutical industry (IQ MPS affiliate) workshop on the standardization of complex in vitro models in drug development","volume":"8","author":"Tomlinson","year":"2024","journal-title":"Adv Biol (Weinh)"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106467_bib50","article-title":"Validation of microphysiological systems for interpreting patient heterogeneity requires robust reproducibility analytics and experimental metadata","volume":"5","author":"Miedel","year":"2025","journal-title":"Cell Rep Methods"},{"issue":"18","key":"10.1016\/j.ebiom.2026.106467_bib51","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1039\/D1LC00348H","article-title":"Simulating drug concentrations in PDMS microfluidic organ chips","volume":"21","author":"Grant","year":"2021","journal-title":"Lab Chip"},{"key":"10.1016\/j.ebiom.2026.106467_bib52","series-title":"The national academies collection: reports funded by national institutes of health","article-title":"Foundational research gaps and future directions for digital twins","year":"2024"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106467_bib53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41746-024-01073-0","article-title":"Digital twins for health: a scoping review","volume":"7","author":"Katsoulakis","year":"2024","journal-title":"NPJ Digit Med"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106467_bib54","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s40262-021-01045-7","article-title":"In silico modeling and simulation to guide bioequivalence testing for oral drugs in a virtual population","volume":"60","author":"Zhang","year":"2021","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106467_bib55","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/psp4.12134","article-title":"Applied concepts in PBPK modeling: how to build a PBPK\/PD model","volume":"5","author":"Kuepfer","year":"2016","journal-title":"CPT Pharmacometr Syst Pharmacol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106467_bib56","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s44287-024-00025-w","article-title":"A roadmap for the development of human body digital twins","volume":"1","author":"Tang","year":"2024","journal-title":"Nat Rev Electr Eng"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106467_bib57","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/psp4.12646","article-title":"Data-driven personalization of a physiologically based pharmacokinetic model for caffeine: a systematic assessment","volume":"10","author":"Fendt","year":"2021","journal-title":"CPT Pharmacometr Syst Pharmacol"},{"key":"10.1016\/j.ebiom.2026.106467_bib58","doi-asserted-by":"crossref","DOI":"10.1007\/s10404-021-02434-x","article-title":"Investigating oxygen transport efficiencies in precision-cut liver slice-based organ-on-a-chip devices","volume":"25","author":"Christensen","year":"2021","journal-title":"Microfluidics Nanofluidics"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106467_bib59","doi-asserted-by":"crossref","DOI":"10.1063\/5.0011353","article-title":"Simulation of nanoparticle transport and adsorption in a microfluidic lung-on-a-chip device","volume":"14","author":"Amin Arefi","year":"2020","journal-title":"Biomicrofluidics"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106467_bib60","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1039\/C3LC51160J","article-title":"Oxygen levels in thermoplastic microfluidic devices during cell culture","volume":"14","author":"Ochs","year":"2014","journal-title":"Lab Chip"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106467_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0314083","article-title":"DigiLoCS: a leap forward in predictive organ-on-chip simulations","volume":"20","author":"Aravindakshan","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2026.106467_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2024.101011","article-title":"Beyond the basics: a deep dive into parameter estimation for advanced PBPK and QSP models","volume":"56","author":"Toshimoto","year":"2024","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.ebiom.2026.106467_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.mbs.2020.108306","article-title":"Sensitivity analysis methods in the biomedical sciences","volume":"323","author":"Qian","year":"2020","journal-title":"Math Biosci"},{"key":"10.1016\/j.ebiom.2026.106467_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.18.00069","article-title":"A review of cell-based computational modeling in cancer biology","volume":"3","author":"Metzcar","year":"2019","journal-title":"JCO Clin Cancer Inform"},{"key":"10.1016\/j.ebiom.2026.106467_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107190","article-title":"Drug transport modeling in solid tumors: a computational exploration of spatial heterogeneity of biophysical properties","volume":"163","author":"Salavati","year":"2023","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.ebiom.2026.106467_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/psp4.70083","article-title":"State-of-the-Art on model-informed drug development approaches for pediatric rare diseases","author":"Krishna","year":"2025","journal-title":"CPT Pharmacometr Syst Pharmacol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106467_bib67","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1021\/acs.chemrestox.5c00033","article-title":"Machine learning for toxicity prediction using chemical structures: pillars for success in the real world","volume":"38","author":"Seal","year":"2025","journal-title":"Chem Res Toxicol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106467_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pdig.0000801","article-title":"Implicit versus explicit Bayesian priors for epistemic uncertainty estimation in clinical decision support","volume":"4","author":"Blattmann","year":"2025","journal-title":"PLoS Digit Health"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106467_bib69","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70056","article-title":"Practical guide to SHAP analysis: explaining supervised machine learning model predictions in drug development","volume":"17","author":"Ponce-Bobadilla","year":"2024","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.ebiom.2026.106467_bib70","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1016\/j.csbj.2024.09.030","article-title":"Towards generative digital twins in biomedical research","volume":"23","author":"Wu","year":"2024","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.ebiom.2026.106467_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.coche.2025.101150","article-title":"Industrial agentic AI and generative modeling in complex systems","volume":"48","author":"Boskabadi","year":"2025","journal-title":"Curr Opin Chem Eng"},{"key":"10.1016\/j.ebiom.2026.106467_bib72","doi-asserted-by":"crossref","DOI":"10.46471\/gigabyte.128","article-title":"PhysiCell studio: a graphical tool to make agent-based modeling more accessible","volume":"2024","author":"Heiland","year":"2024","journal-title":"GigaByte"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106467_bib73","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae509","article-title":"Building multiscale models with PhysiBoSS, an agent-based modeling tool","volume":"25","author":"Ruscone","year":"2024","journal-title":"Brief Bioinform"},{"issue":"513","key":"10.1016\/j.ebiom.2026.106467_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay2574","article-title":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients","volume":"11","author":"Ooft","year":"2019","journal-title":"Sci Transl Med"},{"issue":"6378","key":"10.1016\/j.ebiom.2026.106467_bib75","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106467_bib76","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s43856-022-00209-1","article-title":"Performance assessment and economic analysis of a human liver-chip for predictive toxicology","volume":"2","author":"Ewart","year":"2022","journal-title":"Commun Med (Lond)"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106467_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45297-8","article-title":"Systematic review: predictive value of organoids in colorectal cancer","volume":"13","author":"Sakshaug","year":"2023","journal-title":"Sci Rep"},{"issue":"23","key":"10.1016\/j.ebiom.2026.106467_bib78","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1158\/1078-0432.CCR-25-1564","article-title":"Patient-derived organoids predict treatment response in metastatic colorectal cancer","volume":"31","author":"Smabers","year":"2025","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106467_bib79","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/DCR.0000000000002511","article-title":"Patient-derived tumor organoids can predict the progression-free survival of patients with stage IV colorectal cancer after surgery","volume":"66","author":"Wang","year":"2023","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106467_bib80","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13046-023-02683-4","article-title":"Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study","volume":"42","author":"Jensen","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106467_bib81","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.annonc.2021.04.003","article-title":"Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020","volume":"32","author":"Haslam","year":"2021","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106467_bib82","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.celrep.2019.01.068","article-title":"Rectal organoids enable personalized treatment of cystic fibrosis","volume":"26","author":"Berkers","year":"2019","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106467_bib83","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jcf.2024.04.016","article-title":"Centralized intestinal organoid generation is a feasible and safe approach for personalized medicine as demonstrated in the HIT-CF Europe organoid study","volume":"23","author":"Bierlaagh","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"13","key":"10.1016\/j.ebiom.2026.106467_bib84","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1080\/14656566.2017.1359255","article-title":"Ataluren in cystic fibrosis: development, clinical studies and where are we now?","volume":"18","author":"Zainal Abidin","year":"2017","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106467_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101346","article-title":"Insights into post-marketing clinical validation of companion diagnostics with reference to the FDA, EMA, PMDA, and MFDS","volume":"32","author":"Kang","year":"2024","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106467_bib86","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41698-021-00168-1","article-title":"Patient-derived organoids as a predictive biomarker for treatment response in cancer patients","volume":"5","author":"Wensink","year":"2021","journal-title":"NPJ Precis Oncol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106467_bib90","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/jama.2020.8651","article-title":"Research and development costs of new drugs-reply","volume":"324","author":"Wouters","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106467_bib91","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/alz.12450","article-title":"The costs of developing treatments for Alzheimer\u2019s disease: a retrospective exploration","volume":"18","author":"Cummings","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106467_bib92","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/alzrt269","article-title":"Alzheimer\u2019s disease drug-development pipeline: few candidates, frequent failures","volume":"6","author":"Cummings","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.ebiom.2026.106467_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105170","article-title":"Establishing virtual bioequivalence and clinically relevant specifications using in vitro biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. case example: Naproxen","volume":"143","author":"Loisios-Konstantinidis","year":"2020","journal-title":"Eur J Pharm Sci"},{"issue":"14","key":"10.1016\/j.ebiom.2026.106467_bib95","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1001\/jama.296.14.1731","article-title":"Translation of research evidence from animals to humans","volume":"296","author":"Hackam","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2026.106467_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.crneur.2023.100104","article-title":"Introducing individual sentience profiles in nonhuman primate neuroscience research","volume":"5","author":"Kaufmann","year":"2023","journal-title":"Curr Res Neurobiol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106467_bib97","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13046-023-02853-4","article-title":"Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer","volume":"42","author":"Cartry","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106467_bib98","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.stem.2022.04.006","article-title":"Patient-derived micro-organospheres enable clinical precision oncology","volume":"29","author":"Ding","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106467_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126572","article-title":"Patient-derived tumor organoids for guidance of personalized drug therapies in recurrent glioblastoma","volume":"23","author":"Ratliff","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106467_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100103","article-title":"Prospective experimental treatment of colorectal cancer patients based on organoid drug responses","volume":"6","author":"Ooft","year":"2021","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106467_bib101","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13046-024-02980-6","article-title":"Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response","volume":"43","author":"Smabers","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106467_bib102","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00156-2024","article-title":"Precision medicine in cystic fibrosis: predictive role of forskolin-induced swelling assay","volume":"63","author":"Furstova","year":"2024","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106467_bib103","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jcf.2025.08.011","article-title":"Correlation between patient-derived intestinal organoids and clinical responses to CFTR modulators in people with cystic fibrosis homozygous for F508del","volume":"24","author":"Rodriguez Mier","year":"2025","journal-title":"J Cyst Fibros"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426003518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426003518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:21:12Z","timestamp":1791966072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426003518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":97,"alternative-id":["S2352396426003518"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106467","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integration of biological avatars and digital twins for \u201cex vivo clinical trials\u201d","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106467"}}